跳至主要内容
临床试验/NCT03105921
NCT03105921已完成不适用

Intérêt de l'électroporation irréversible Dans le Traitement de l'adénocarcinome du pancréas

Poitiers University Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年10月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
R0 resection rate

研究概览

简要总结

The aim of the study is to evaluate the use of irreversible electroporation in the treatment of locally advanced cancers of the head of pancreas with vascular spread. This technique would allow to treat the unresectable part of the tumor to make it more accessible for a secondary surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with histologically proven adenocarcinoma of the head of the pancreas (fine needle aspiration or biopsy)
  • •Pancreatic adenocarcinoma locally advanced on imaging at diagnosis
  • •Tumor of less than 7 cm in largest diameter
  • •No chemotherapy or abdominal radiotherapy within five years before the inclusion in the study

排除标准

  • •Pancreatic adenocarcinoma of more than 7 cm of diameter or immediately operable on imaging data
  • •Patient with contraindication of NanoKnife use
  • •Patient with neurostimulator
  • •Epileptic patient or with a myocardial infarction lasting less than 2 months
  • •Presence of visceral or lymph node metastases or peritoneal carcinosis at the initial workup
  • •Patient who cannot be treated with muscle blockers (curare)
  • •Patient with a metallic stent or a medical device implanted near the area treated by electroporation

研究组 & 干预措施

Electrodes

Experimental

Electrodes

干预措施: NanoKnife (Device)

结局指标

主要结局

R0 resection rate

时间窗: 3 months

Assessment of the R0 resection (complete tumour removal with negative resection margins) rate of locally advanced pancreatic cancer treated by electroporation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验